We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Caesarstone
CSTE
$69.5M
| $212K | 0.01% |
+107,449
| New | +$243K |
|
1452
MillerKnoll
MLKN
$1.56B
| $209K | 0.01% |
+10,767
| New | +$184K |
|
1453
Ituran Location and Control
ITRN
$1.08B
| $209K | 0.01% |
+5,391
| New | +$194K |
|
1454
ProKidney
PROK
$316M
| $208K | 0.01% |
+351,622
| New | +$274K |
|
|
FLOC
1455
Flowco Holdings
FLOC
$811M
| $208K | 0.01% |
+11,684
| New | +$223K |
|
|
1456
Walmart Inc
WMT
$909B
| $207K | 0.01% |
2,122
-113,095
| -98% | -$10.8M |
|
1457
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.29B
| $207K | 0.01% |
3,465
-6,553
| -65% | -$374K |
|
1458
Washington Trust Bancorp
WASH
$748M
| $206K | 0.01% |
+7,291
| New | +$203K |
|
1459
Kearny Financial
KRNY
$604M
| $206K | 0.01% |
31,901
-32,672
| -51% | -$201K |
|
1460
Destination XL Group
DXLG
$32.9M
| $206K | 0.01% |
+185,459
| New | +$203K |
|
1461
iShares MSCI Mexico ETF
EWW
$1.89B
| $205K | 0.01% |
+3,382
| New | +$195K |
|
1462
Ardelyx
ARDX
$1.24B
| $204K | 0.01% |
+52,130
| New | +$215K |
|
1463
Unitil
UTL
$989M
| $204K | 0.01% |
3,918
+105
| +3% | +$5.82K |
|
|
NEXN
1464
Nexxen International
NEXN
$588M
| $204K | 0.01% |
+19,587
| New | +$199K |
|
|
INN
1465
Summit Hotel Properties
INN
$766M
| $203K | 0.01% |
+39,907
| New | +$176K |
|
|
SCS
1466
DELISTED
Steelcase
SCS
| $202K | ﹤0.01% |
+19,381
| New | +$200K |
|
|
BELFB
1467
Bel Fuse Inc Class B
BELFB
$3.45B
| $202K | ﹤0.01% |
+2,068
| New | +$156K |
|
1468
Enerpac Tool Group
EPAC
$1.86B
| $202K | ﹤0.01% |
+4,970
| New | +$209K |
|
1469
Under Armour
UAA
$3.01B
| $200K | ﹤0.01% |
+29,287
| New | +$182K |
|
1470
Wheels Up
UP
$203M
| $198K | ﹤0.01% |
+9,243
| New | +$227K |
|
1471
Cleveland-Cliffs
CLF
$6.49B
| $197K | ﹤0.01% |
+25,901
| New | +$193K |
|
1472
ChargePoint
CHPT
$134M
| $195K | ﹤0.01% |
+13,850
| New | +$186K |
|
1473
Mativ Holdings
MATV
$479M
| $192K | ﹤0.01% |
28,107
-81,226
| -74% | -$468K |
|
1474
Sera Prognostics
SERA
$80.3M
| $188K | ﹤0.01% |
+67,692
| New | +$168K |
|
1475
The Honest Company
HNST
$412M
| $185K | ﹤0.01% |
36,406
-8,982
| -20% | -$43K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.